Innovative Reproductive Solutions Launches Medical Test for Infertility
05/11/2012

Innovative Reproductive Solutions, a distributor of women’s reproductive devices and diagnostic tests, has announced the launch of a new medical testing service to help women recognize the causes of infertility.

Online PR News – 11-May-2012 – Boston MA – Innovative Reproductive Solutions, a distributor of women’s reproductive devices and diagnostic tests, has announced the launch of a new medical testing service to help women recognize the causes of infertility. The test, medically referred to as the E-tegrity Test, is used to determine how receptive the lining of the uterus is to the implantation of the fertilized egg. The test mainly checks for the presence of the Beta-3 integrin, a glue-like protein necessary for success in implantation.

Infertility affects approximately six million people in the United States every year. About 15% to 20% of the time, the reason for infertility cannot be identified. This can lead to treatments that may be both stressful and expensive, and yet not show any results. The E-tegrity test helps healthcare providers identify the possible causes of infertility.

Innovative Reproductive Solutions also helps patients find a physician who can perform the E-tegrity test at the nearest possible location. The company believes that a negative test result can be caused by one of two conditions. The first condition which is called “out of phase” occurs when the development of the uterine lining is delayed. The second condition called “in phase” means that the lining of the uterus has developed properly but the Beta-3 integrin is still missing. Based on the reportings of the test, doctors can assess the results and provide the proper treatment path resulting in higher IVF success rates.

Talking about the importance of the test, Dr. Bruce Lessey MD, PhD said, “In a recent study just published, we found that the beta 3 integrin was highly predictive for IVF failure. We continue to refine the use of this test and have recently completed a prospective study on unexplained infertility that reveals that other key proteins important for implantation are also defective in these women that lack the beta 3 integrin.”

About the Company: Innovative Reproductive Solutions is passionate about bringing the latest cutting edge technology to women and couples who are trying to conceive. The company provides advisory and laboratory services for females trying to conceive. It is a women-owned and operated business located in Boston, MA, and works with clients from all over the world.

Contact Info.

Company name: Innovative Reproductive Solutions
Name: Ellen Berman
180 Lincoln Street, 4th Floor
Boston MA 02111
Tel No: 877-981-4141, 857-204-7904, 617-956-9919
E-mail Id: info@InnovativeReproductiveSolutions.com
Website : www.etegritytest.com